biopharmaceutical Archives

Home / Posts tagged biopharmaceutical

Zenas BioPharma Strengthens Executive Leadership with Appointment of Jennifer Fox as Chief Business Officer and Chief Financial Officer and Tanya Fischer, M.D., PhD. as Head of R&D and Chief Medical Officer

Expanded strategic and operational leadership positions Zenas for growth as obexelimab advances in late-stage clinical trials for multiple potential I&I indications WALTHAM, Mass., Dec. 04, 2023 (Korea Bizwire) – Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and immunology (I&I) directed therapies, today announced the [...]

S. Korea to Designate Biopharma as Nat’l Strategic Industry, Double Bio Exports by 2030

SEOUL, July 19 (Korea Bizwire) — South Korea will push to designate biopharmaceutical manufacturing as a national strategic technology, and extend support for the development of indigenous raw materials and equipment in the field with a goal to become the world’s top biotech economy by 2030, the industry ministry said Wednesday. The move is part [...]

SK Pharmteco Eyes US$2 bln Annual Sales by 2025 with Cell and Gene Therapy Biz

SEOUL, Jan. 11 (Korea Bizwire) — SK Pharmteco Inc., a biopharmaceutical arm of South Korea’s No. 3 conglomerate SK Group, aims to generate US$2 billion in annual sales in the next three years with a focus on cell and gene therapy business, its parent company SK Inc. said Tuesday. Aslam Malik, CEO of SK’s contract [...]

S. Korea’s Biopharmaceutical Exports More than Double in 2020

SEOUL, July 26 (Korea Bizwire) — South Korea’s exports of biopharmaceutical products more than doubled in 2020 from a year earlier on the back of the growing demand for pharmaceutical products amid the COVID-19 pandemic, a report showed Monday. Outbound shipments of high-end biopharmaceutical products came to US$5.1 billion in 2020, compared with around $2.1 [...]

Checkpoint Therapeutics Initiates Registrational Development Programs for Anti-PD-L1 Antibody CK-301

NEW YORK, Jan. 7 (Korea Bizwire) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers, today announced that the ongoing multi-center clinical trial of CK-301 has been expanded to enroll patients in three cohorts intended to [...]

Business Update and Change of Name from Pro Bono Bio

LONDON, Jan. 4 (Korea Bizwire) – Ascension Healthcare plc (“Ascension” or the “Company”), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapies for haemophilia and osteoarthritis today provides a business update and announces a Company change of name from Pro Bono Bio. BUSINESS UPDATE Haemophilia SelectAte Phase II clinical development programme initiated to [...]

Autolus Announces Pricing of Initial Public Offering

LONDON, Jun. 22 (Korea Bizwire) – Autolus Therapeutics plc (“Autolus”), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced the pricing of its initial public offering in the United States of 8,823,530 American Depositary Shares (“ADSs”) representing 8,823,530 ordinary shares at an initial public offering price of $17.00 per ADS for total [...]

Celltrion’s Truxima Drug to Sell in Colombia

SEOUL, Feb. 21 (Korea Bizwire) — South Korean biopharmaceutical firm Celltrion Inc.’s biosimilar drug Truxima will reach the Colombian market, the company’s affiliate said Wednesday. Global drug firm Mundi Pharma Inc. won exclusive rights to distribute and market the copy of Roche’s blockbuster medicine, also known as MabThera, in the South American country, Celltrion Healthcare [...]

Celltrion Head Becomes 4th-richest Man in Stock Holdings in S. Korea amid Bio Boom: Data

SEOUL, Jan. 8 (Korea Bizwire) — The head of a biotech venture firm has emerged as the fourth-richest man in stock holdings in South Korea, industry data showed Sunday, amid a bio venture boom in Asia’s fourth-biggest economy. The value of stocks held by Seo Jung-jin, chairman of biopharmaceutical firm Celltrion Inc., rose to 5.39 [...]

RedHill Biopharma Provides 2017 Semi-Annual Business Update

TEL-AVIV, Israel and RALEIGH, N.C., Aug. 10 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today provided an update on key programs, potential milestones [...]